BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10864683)

  • 1. Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine.
    Halvas EK; Svarovskaia ES; Freed EO; Pathak VK
    J Virol; 2000 Jul; 74(14):6669-74. PubMed ID: 10864683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
    Boyer PL; Gao HQ; Clark PK; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 Jul; 75(14):6321-8. PubMed ID: 11413298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
    McCrackin Stevenson MA; McBroom DG
    Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
    Smith RA; Remington KM; Preston BD; Schinazi RF; North TW
    J Virol; 1998 Mar; 72(3):2335-40. PubMed ID: 9499094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine.
    Cherry E; Slater M; Salomon H; Rud E; Wainberg MA
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2763-5. PubMed ID: 9420055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides.
    Smith RA; Remington KM; Lloyd RM; Schinazi RF; North TW
    J Virol; 1997 Mar; 71(3):2357-62. PubMed ID: 9032372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.
    Halvas EK; Svarovskaia ES; Pathak VK
    J Virol; 2000 Jan; 74(1):312-9. PubMed ID: 10590119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
    Melegari M; Scaglioni PP; Wands JR
    Hepatology; 1998 Feb; 27(2):628-33. PubMed ID: 9462667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valine of the YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the fidelity of DNA synthesis.
    Kaushik N; Chowdhury K; Pandey VN; Modak MJ
    Biochemistry; 2000 May; 39(17):5155-65. PubMed ID: 10819983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK; Jablonski SA; Morrow CD
    J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.
    Wainberg MA; Drosopoulos WC; Salomon H; Hsu M; Borkow G; Parniak M; Gu Z; Song Q; Manne J; Islam S; Castriota G; Prasad VR
    Science; 1996 Mar; 271(5253):1282-5. PubMed ID: 8638110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase.
    Rezende LF; Drosopoulos WC; Prasad VR
    Nucleic Acids Res; 1998 Jun; 26(12):3066-72. PubMed ID: 9611256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
    García-Lerma JG; Nidtha S; Heneine W
    J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.
    Ladner SK; Miller TJ; Otto MJ; King RW
    Antivir Chem Chemother; 1998 Jan; 9(1):65-72. PubMed ID: 9875378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity.
    Rinke CS; Boyer PL; Sullivan MD; Hughes SH; Linial ML
    J Virol; 2002 Aug; 76(15):7560-70. PubMed ID: 12097569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.
    Balzarini J; Pelemans H; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 May; 49(5):882-90. PubMed ID: 8622638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.
    Boucher CA; Cammack N; Schipper P; Schuurman R; Rouse P; Wainberg MA; Cameron JM
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2231-4. PubMed ID: 7504909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.
    Murry JP; Higgins J; Matthews TB; Huang VY; Van Rompay KK; Pedersen NC; North TW
    J Virol; 2003 Jan; 77(2):1120-30. PubMed ID: 12502828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.